AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Total Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Liabilities | ₹4,705 Cr | ₹4,197 Cr | ₹4,109 Cr | ₹3,572 Cr | ₹2,906 Cr |
What is the latest Total Liabilities ratio of AJANTA PHARMA ?
Year | Total Liabilities |
---|---|
Mar2023 | ₹4,705 Cr |
Mar2022 | ₹4,197 Cr |
Mar2021 | ₹4,109 Cr |
Mar2020 | ₹3,572 Cr |
Mar2019 | ₹2,906 Cr |
How is Total Liabilities of AJANTA PHARMA Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹4,705 Cr | 12.10 | |
Mar2022 | ₹4,197 Cr | 2.14 | |
Mar2021 | ₹4,109 Cr | 15.03 | |
Mar2020 | ₹3,572 Cr | 22.93 | |
Mar2019 | ₹2,906 Cr | - |
Compare Total Liabilities of peers of AJANTA PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AJANTA PHARMA | ₹30,139.2 Cr | -0.2% | 8.3% | 87.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹354,706.0 Cr | -1.1% | -2.9% | 55.1% | Stock Analytics | |
CIPLA | ₹120,556.0 Cr | 0.3% | 6.1% | 56.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹118,095.0 Cr | 8.2% | 11.5% | 27.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,162.0 Cr | -3.7% | 8.5% | 107.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,086.0 Cr | 1.8% | -4.7% | 32.3% | Stock Analytics |
AJANTA PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AJANTA PHARMA | -0.2% |
8.3% |
87.5% |
SENSEX | 0.4% |
1.1% |
20.6% |
You may also like the below Video Courses